# A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout

> **NCT00741442** · PHASE2 · COMPLETED · sponsor: **Ardea Biosciences, Inc.** · enrollment: 3 (actual)

## Conditions studied

- Hyperuricemia

## Interventions

- **DRUG:** RDEA806
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00741442
- **Lead sponsor:** Ardea Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-04
- **Final completion:** 2009-09
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2014-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00741442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00741442, "A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00741442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*